Clinical Trial Update: Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating mobile health technology to enhance abstinence in smokers with schizophrenia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cigarette Smoking
• Schizophrenia

Snippet

Sponsor: Duke University | Conditions: Schizophrenia, Cigarette Smoking | Phase 4 | Status: COMPLETED | Results posted: 2019-07-10